ResearcherUniversity of MichiganNo recent work listed
Mahmoud M. Al-Hawary
Matched on ORCID iD 0000-0002-3699-1147; OpenAlex author ID A5074668249. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 62
2013: 3 papers · 2014: 3 papers · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper
Papers 11
- Imaging Assessment of Pancreatic Cancer Resectability After Neoadjuvant Therapy: AJR Expert Panel Narrative Review. First author DOI 10.2214/ajr.21.26931↗
- Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Co-author DOI 10.6004/jnccn.2021.0017↗
- Pancreatic Adenocarcinoma, Version 1.2019. Co-author DOI 10.6004/jnccn.2019.0014↗
- Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. Co-author DOI 10.6004/jnccn.2017.0131↗
- Role of Imaging in Diagnosing and Staging Pancreatic Cancer. Co-author DOI 10.6004/jnccn.2016.0191↗
- A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. Co-author DOI 10.1016/j.tranon.2014.07.005↗
- Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic associatio… Co-author DOI 10.1053/j.gastro.2013.11.004↗
- Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Associatio… Co-author DOI 10.1148/radiol.13131184↗
- Staging of pancreatic cancer: role of imaging. Co-author DOI 10.1053/j.ro.2013.03.005↗
- Mimics of pancreatic ductal adenocarcinoma. Co-author DOI 10.1102/1470-7330.2013.9012↗
- Pancreatic ductal adenocarcinoma staging. Co-author DOI 10.1102/1470-7330.2013.9020↗
Closest collaborators
The 25 strongest of 62 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Elliot K. Fishman · 3 shared papers, 2014–2022 · strength 0.26
- Paper Imaging Assessment of Pancreatic Cancer Resectability After Neoadjuvant Therapy: AJR Expert Panel Narrative Review. DOI 10.2214/ajr.21.26931↗
- Paper Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiolog… DOI 10.1053/j.gastro.2013.11.004↗
- Paper Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiolog… DOI 10.1148/radiol.13131184↗
- Isaac R. Francis · 5 shared papers, 2013–2014 · strength 0.25
- William G. Hawkins · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Andrew H. Ko · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Brian G. Czito · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Noelle K. LoConte · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Sushanth Reddy · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Efrat Dotan · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Robert A. Wolff · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Courtney L. Scaife · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Stephen W. Behrman · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Eric K. Nakakura · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Mokenge Peter Malafa · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Cristina Rosa Ferrone · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Jeffrey M. Hardacre · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Brian Matthew Wolpin · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Dana Backlund Cardin · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Mary E. Dillhoff · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Andrew M. Lowy · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Vincent M. Chung · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Margaret A. Tempero · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Al B. Benson · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Elena Gabriela Chiorean · 3 shared papers, 2017–2021 · strength 0.19
- Paper Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2021.0017↗
- Paper Pancreatic Adenocarcinoma, Version 1.2019. DOI 10.6004/jnccn.2019.0014↗
- Paper Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. DOI 10.6004/jnccn.2017.0131↗
- Marc Zins · 1 shared paper, 2022 · strength 0.19
- Erik V. Soloff · 1 shared paper, 2022 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.